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From Lesions to Leptin: Review
Hypothalamic Control
of Food Intake and Body Weight
the hypothalamus. Examination of these lesions has
shown them to be very large, but they all have in
common extensive bilateral damage to the region
occupied by the dorsomedial and ventromedial hy-
pothalamic nuclei, the arcuate nucleus, the fornix,
Joel K. Elmquist,*² Carol F. Elias,*²
and Clifford B. Saper*³
*Department of Neurology and Program in
Neuroscience
²Department of Medicine and Division of Endocrinology
and that portion of the lateral hypothalamic area ven-Beth Israel Deaconess Medical Center and
tral to it, and probably also the ventral premammillaryHarvard Medical School
nuclei.Boston, Massachusetts 02215
Conversely, Hetherington and Ranson noted that le-
sions in the adjacent lateral hypothalamus could leadBody weight seems to run within families. However, until
to decreased food intake (Hetherington and Ranson,recently, the contribution of genetics to obesity was not
1940; Stevenson, 1970). Anand and Brobeck (1951) pur-clear. The identification over the last few years of a
sued this observation in greater detail, demonstratingnumber of different genetic mutations in signaling mole-
that lesions of the lateral hypothalamus at the level adja-cules and their receptors that result in changes in body
cent to the ventromedial nucleus caused loss of feeding,weight has redefined this field of neuroscience (Spiegel-
inanition, and even death by starvation. Thus, the con-man and Flier, 1996; Flier, 1998; Friedman and Halaas,
cept arose of the lateral hypothalamic area serving as1998; Woods et al., 1998). By exploring the brain systems
a ªfeeding centerº and the ventromedial nucleus as athat employ recently identified signaling molecules, it
ªsatiety centerº (Figure 1).has been possible to redefine the hypothalamic path-
This model was attacked over the ensuing years byways involved in the regulation of feeding and body
revisionists using more refined experimental methodol-weight (Elmquist et al., 1998a; Woods et al., 1998). For
ogies. Gold and colleagues found that smaller lesionsa more general discussion of metabolic, autonomic, and
confined to the ventromedial nucleus were not effectiveendocrine factors affecting feeding, the reader is re-
in producing hyperphagia but that more dorsally placedferred to a recent review by Woods et al. (1998).
lesions, disrupting the connections of the paraventricu-
lar nucleus, often were more effective (Gold, 1973). The
The Dual Center Model for Regulation of Feeding paraventricular nucleus is a major source of input to the
Most neuroscientists have grown up with the classic sympathetic and parasympathetic preganglionic neu-
ªdual centerº model for understanding the role of the rons controlling the gastrointestinal tract, suggesting
brain in regulation of feeding (Stellar, 1954). This model that the changes in feeding might be consequent to
was derived originally from clinical observations in pa- autonomic alterations (Saper et al., 1976; Swanson and
tients with FroÈ hlich's syndrome: pituitary tumors associ- Kuypers, 1980; Saper, 1995). To test this hypothesis,
ated with excessive subcutaneous fat and hypogo- Opsahl and Powley (1974) and several subsequent
nadism (Bramwell, 1888; FroÈ hlich, 1901). Whether this groups examined the effect of severing the abdominal
adiposogenital syndrome was due to injury to the pitu- vagus nerve in rats with large lesions of the ventromedial
itary gland (as FroÈ hlich concluded at the time) or to the nucleus, finding that subdiaphragmatic vagotomy pre-
overlying hypothalamus was controversial. Cushing, for vented the hyperphagia and obesity (Inoue and Bray,
example, championed the view that FroÈ hlich's syndrome 1977; Berthoud and Jeanrenaud, 1979; Gold et al., 1980;
was due to hypophysial insufficiency (Crowe et al., Bray et al., 1981; Cox and Powley, 1981; Sclafani et al.,
1910). In 1912, Aschner demonstrated in dogs that mere 1981). At the same time, several groups pointed out that
removal of the pituitary gland without damage to the over- the lateral hypothalamic lesions that cause hypophagia
lying hypothalamus did not result in obesity (Aschner, interrupt the ascending nigrostriatal bundle, resulting in
1912). a Parkinsonian syndrome and reduction in virtually all
The role of the hypothalamus in regulating food intake movement and behavior (see Ungerstedt, 1970; Stricker
and body weight was finally established in 1940 with and Zigmond, 1976; Stricker and Verbalis, 1990; Ber-
the classic experiments of Hetherington and Ranson. nardis and Bellinger, 1996).
They used the Horsley±Clarke stereotaxic apparatus to
place bilateral electrolytic lesions in the hypothalamus of New Molecular Probes Verify the Presence
rats, without disturbing the pituitary gland (Hetherington of Lateral Hypothalamic Phagic Neurons
and Ranson, 1940). They summarized these experi- Observations such as these questioned the validity of
ments by stating: the dual center model and the role of the lateral hypotha-
lamic area and the ventrobasal hypothalamus in control-
A condition of marked adiposity characterized by as ling food intake (Bernardis and Bellinger, 1987, 1996).
much as a doubling of body weight and a tremendous Nevertheless, as cell-specific lesion methods emerged,
increase of extractable body lipids has been pro- they refocused attention on the ventromedial and lateral
duced in rats by the placing of electrolytic lesions in hypothalamic syndromes. Lateral hypothalamic lesions
produced by kainic acid resulted in hypophagia, even
when the ascending dopaminergic system was not dam-³ To whom correspondence should be addressed (e-mail: csaper@
caregroup.harvard.edu). aged (Grossman et al., 1978; Stricker et al., 1978). The
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Figure 1. A Schematic Drawing of the Rat Hypothalamus in Sagittal
Section Illustrating the Dual Center Hypothesis for Hypothalamic
Control of Feeding
The most effective lesions for producing hyperphagia and obesity Figure 2. MCH±Immunoreactive and Agouti-Related Protein±Immu-
typically involved both the ventromedial (VMH) and arcuate (ARC) noreactive Neurons in the Hypothalamus of the Human Brain
nuclei (illustrated in red, because these pathways normally inhibit
Note the presence in (A) of a cluster of MCH-IR neurons draped over
eating). Aphagia and weight loss were produced by lateral hypotha-
the fornix (fx) and others spread among the fibers of the lenticular
lamic (LHA) lesions at the same level of the hypothalamus (illustrated
fasciculus (lf). In another section from the same brain (B), AgRP-IR
in green, because these pathways normally increase feeding). Other
cell bodies are seen in the arcuate nucleus (Arc). AgRP-IR axons
abbreviations: DMH, dorsomedial hypothalamic nucleus; ME, me-
run dorsally and laterally in a dense bundle into the region of the
dian eminence; OC, optic chiasm; PVH, paraventricular hypotha-
lateral hypothalamus containing the MCH and ORX neurons. Scale,
lamic nucleus; SCn, suprachiasmatic nucleus; and SPV, subpara-
2 mm.
ventricular zone.
possibility that the lateral hypothalamus was involved the substrate for Anand and Brobeck's lateral hypotha-
lamic feeding center.in feeding was further supported by neuroanatomical
studies showing a lateral hypothalamic cell system with The specific CNS sites targeted by MCH and ORX
neurons that are involved in feeding are not yet known.direct projections both to the cerebral cortex and to the
autonomic and motor systems of the brainstem and the It therefore will be interesting to determine whether they
include key autonomic regions such as the medial pre-spinal cord. This extensive system with both ascending
and descending connections was predicted to have the frontal cortex (infralimbic and prelimbic areas), the insu-
lar cortex, the parabrachial nucleus, and the dorsal vagalnecessary anatomical range to support a lateral hypo-
thalamic phagic function (Saper, 1985; Saper et al., 1986; complex, as well as premotor neuronal pools in the
brainstem and the spinal cord, which may control ste-Bittencourt et al., 1992). This prediction was confirmed
by the subsequent discovery that lateral hypothalamic reotyped feeding motor patterns (Bittencourt et al.,
1992; Sawchenko, 1998).neurons contain two newly recognized neuropeptides,
melanin concentrating hormone (MCH) (Bittencourt et Recent evidence suggests that neuropeptides that
decrease food intake and body weight may also be ex-al., 1992) and the orexins (ORX) (Sakurai et al., 1998),
also called hypocretin (de Lecea et al., 1998). MCH and pressed in the lateral hypothalamic area, and these may
play a counterregulatory role, opposing the systems thatORX are found in separate but spatially overlapping
populations of neurons in the perifornical region, lateral increase food intake. One such peptide, CART (cocaine
and amphetamine regulated transcript) is expressed inhypothalamic area, and zona incerta in the rodent and
human brain (Broberger et al., 1998; Elias et al., 1998a; the lateral hypothalamic area and decreases food intake
when centrally administered (Koylu et al., 1997; Kris-Peyron et al., 1998; see Figures 2A and 3A). Both cell
groups appear to contribute to the entire range of lateral tensen et al., 1998). In addition, corticotropin releasing
hormone mRNA is induced in lateral hypothalamic areahypothalamic neuronal projections, from the cerebral
cortex to the spinal cord (Bittencourt et al., 1992; Brober- neurons that innervate the parabrachial nucleus in a
dehydration-induced model of anorexia (Kelly and Watts,ger et al., 1998; Elias et al., 1998a; Peyron et al., 1998;
see Figure 4). For both of these peptides, the levels of 1996; Kelly and Watts, 1998). As corticotropin releasing
hormone is thought to be anorectic, it is likely that lateralmRNA are increased by starvation (Qu et al., 1996; Sa-
kurai et al., 1998), when leptin levels rapidly fall (Freder- hypothalamic area neurons are influenced by physiolog-
ical stimuli to integrate body weight and food intake. Itich et al., 1995; Ahima et al., 1996), and the MCH mRNA
levels are normalized by refeeding or by leptin adminis- is not known whether the same lateral hypothalamic
neurons can express corticotropin releasing hormonetration (Qu et al., 1996). Injection of either MCH or ORX
into the lateral ventricle causes rats to eat (Qu et al., during dehydration and MCH or ORX during starvation
(see Sawchenko, 1998). If that were so, and the same1996; Sakurai et al., 1998). Moreover, targeted deletion
of the MCH gene results in decreased food intake and lateral hypothalamic neurons were able to produce dif-
ferent neurotransmitters with distinct effects under dif-body weight compared to wild-type control mice (Shi-
mada et al., 1998). Hence, it now seems likely that these fering conditions, it would represent a completely novel
mechanism for the regulation of feeding.specific populations of peptidergic neurons represent
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Figure 3. Dual Localization of Putative Neu-
rotransmitters Involved in the Regulation of
Feeding
(A) shows that the neurons in the lateral hypo-
thalamic area that contain mRNA for MCH
(stained with a blue histochemical reaction
for digoxigenin label [dig]) are entirely distinct
from the population of neurons that contain
ORX (stained immunocytochemically [IR] with
a brown label). Conversely, in (B), nearly all
of the CART-IR neurons (stained brown) in
the lateral arcuate nucleus are overlaid by
autoradiographic silver grains, indicating hy-
bridization for pro-opiomelanocortin (POMC)
mRNA. (C), (D), and (E) demonstrate lateral
hypothalamic neurons in the rat (C and E)
and human (D) brain, stained brown with an
immunocytochemical reaction for MCH or
ORX and apposed by black immunostained
axons that have been labeled with antisera
against agouti-related protein (AgRP) or
a-melanocyte stimulating hormone (aMSH).
Scale bars, 250 mm (A); 100 mm (B); and 50
mm (C±E).
Leptin Action Illuminates a Medial Hypothalamic secrete pituitary releasing hormones into the hypophys-
ial portal circulation, is the median eminence. The ven-Satiety Network
Two earlier lines of evidence had focused attention on tromedial and arcuate nuclei directly overlie the median
eminence, and the experiments of Broadwell and Bright-the medial hypothalamic ventromedial and arcuate nu-
clei in integrating circulating metabolic signals and pro- man (1976) demonstrated that even rather large proteins
such as horseradish peroxidase can enter the medialducing satiety. First, in the early 1960s, Debons et al.
(1962) found that systemic injections of gold thioglucose hypothalamus from the median eminence.
The median eminence is also a candidate site at which(a toxic glucose analog) caused injury to the arcuate and
ventromedial nuclei, producing overeating and obesity circulating hormones, such as leptin, may enter the brain
(Banks et al., 1996). Leptin is a peptide hormone made(Debons et al., 1962). In the late 1960s, Olney and col-
leagues systemically administered monosodium gluta- by white adipose cells (Zhang et al., 1994) during times of
adequate metabolic substrate. Leptin is also producedmate to young mice while exploring the toxicity of food
additives (Olney, 1969). They found a pattern of obesity under certain conditions by other cells such as those
of the placenta (Bi et al., 1997; Masuzaki et al., 1997),and hypothalamic damage that was similar to the lesions
produced by gold thioglucose (and produced some of gastric parietal cells (Bado et al., 1998), and skeletal
muscle cells (Wang et al., 1998). The existence of athe first evidence of glutamate excitotoxicity).
These findings raised the question: why are the lesions protein like leptin was hypothesized by Coleman and
colleagues (Coleman and Hummel, 1969; Coleman, 1973),from these systemically administered toxins so local-
ized? Although it is protected from circulating toxins who studied two mutant mouse strains, the ob/ob mice
and db/db mice, each of which had a phenotype ofby the blood±brain barrier, the brain maintains specific
ªwindows on the circulation,º the circumventricular or- massive overeating, obesity, and delay of sexual matu-
ration, similar to the patients noted clinically by FroÈ hlichgans, for interchanging signaling molecules with the
bloodstream (Broadwell and Brightman, 1976). One of and Cushing. Coleman performed parabiosis experi-
ments, establishing cross-circulation between ob/obthese windows, which is used by the hypothalamus to
Figure 4. A Schematic Drawing Illustrating
the Divergent Projections from the ORX and
MCH Neurons in the Lateral Hypothalamus,
Ascending to the Cerebral Cortex and De-
scending to the Brainstem and Spinal Cord
These neurons are activated during starva-
tion or leptin deprivation, and knockout of the
MCH gene produces hypophagia and lean-
ness, suggesting that these peptides play a
role in the regulation of feeding. Other abbre-
viations are the same as in Figure 1.
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and db/db animals or normal mice. His results sug-
gested that the gene containing the ob mutation en-
coded a secreted peptide, whereas the db/db mouse
had a defect in the corresponding receptor.
These predictions were borne out first by the cloning
of leptin (Zhang et al., 1994) and subsequently its recep-
tor (Tartaglia et al., 1995). It was quickly found that ad-
ministration of leptin to ob/ob mice resulted in marked
decreases in food intake, body weight, and normalized
body temperature and neuroendocrine status (Camp-
field et al., 1995; Halaas et al., 1995; Pelleymounter et
al., 1995). Moreover, mutations of the long form of the
leptin receptor (which include the intracellular signaling
portion of the molecule) were found to underlie the phe-
notype of the db/db mouse (Chen et al., 1996; Lee et Figure 5. A Schematic Drawing Illustrating Cell Groups in the Hypo-
al., 1996) and the Zucker fatty rat (White et al., 1997). thalamus that Respond to the Administration of Leptin as Demon-
Leptin administration to ob/ob mice not only de- strated by Changes in Gene Expression
creases food intake and body weight but also corrects Leptin enters the hypothalamus through the median eminence,
where it can diffuse to interact with neurons expressing high levelsneuroendocrine abnormalities including hypogonadism,
of leptin receptors in the arcuate (ARC), ventromedial (VMH), andhypercorticosteronemia, and low levels of thyroid hor-
dorsomedial (DMH) nuclei. Leptin suppresses the activity of somemone. Leptin-deficient ob/ob mice do not undergo nor-
neurons in the medial arcuate nucleus (shown by a shaded, blue
mal puberty, unless they are given exogenous leptin circle) that demonstrate expression of the signaling molecule
(Barash et al., 1996; Chehab et al., 1996). In normal SOCS-3 but not Fos. Leptin activates neurons that show both Fos
female mice, leptin administration from the time of wean- and SOCS-3 expression (illustrated by open, red circles) in the ARC,
VMH, DMH, and ventral premammillary (not shown) nuclei. Neuronsing accelerates the onset of puberty (Ahima et al., 1997;
of the ventral parvocellular part of the paraventricular nucleus (PVH)Chehab et al., 1997; Cheung et al., 1997a). Patients pre-
project selectively to the dorsal vagal complex. Cells in this groupsenting with FroÈ lich's syndrome, as well as ventromedial
have low levels of leptin receptors but do show Fos expression after
hypothalamus±lesioned animals, in fact have hypogo- systemic administration of leptin, suggesting that they have been
nadism. Taken together, these data suggest that leptin activated by leptin-responsive neuronal pathways. Other abbrevia-
is essential for normal functioning of the reproductive tions are the same as in Figure 1.
system (Barash et al., 1996; Chehab et al., 1996, 1997;
Ahima et al., 1997; Cheung et al., 1997a; Montague et
leptin and regulating body weight. Evidence for this hy-al., 1997). These observations are consistent with the
pothesis is provided by the observation that treatmentsuggestion by Flier and colleagues that the predominant
of mice with gold thioglucose markedly reduces therole of leptin may be to signal the brain about the overall
mRNA for the long form of the leptin receptor in thenutritional state of the individual, rather than to serve
hypothalamus (Fei et al., 1997), confirming that this toxinas a short-term inhibitor of feeding (Flier, 1998).
works by destroying the very cells that leptin engages.The leptin receptor has been identified in the human
Interestingly, cells that bear the highest levels of thebrain (Couce et al., 1997). Mutations in human leptin
receptor mRNA are located in the arcuate nucleus and(Montague et al., 1997; Strobel et al., 1998) and the leptin
parts of the ventromedial, dorsomedial, and ventral pre-receptor (Clement et al., 1998) result in morbid obesity
mammillary nuclei (Hakansson et al., 1996, 1998; Mercerand neuroendocrine derangements, including failure to
et al., 1996a, 1996b; Schwartz et al., 1996; Fei et al.,undergo puberty. Therefore, in humans as well as ro-
1997; Elmquist et al., 1998b). These hypothalamic nucleidents, intact leptin and its long-form receptor are neces-
that cluster around the median eminence constitute ex-sary for leptin signaling and are essential in the mainte-
actly the areas where Hetherington and Ranson foundnance of body weight and energy homeostasis.
electrolytic lesions to cause obesity.The long form of the leptin receptor is expressed in
a relatively restricted distribution in the hypothalamus
Mapping the Effects of Leptin on the Brain(Mercer et al., 1996a; Schwartz et al., 1996; Cheung et
The expression of immediate-early genes, particularlyal., 1997b; Fei et al., 1997; Guan et al., 1997; Elmquist
c-fos, by neurons in the brain that have been activatedet al., 1998b). The highest levels of leptin receptor mRNA
by systemic administration of leptin has allowed impor-and protein are found in the ventrobasal hypothalamus.
tant insights into actions of leptin in the CNS (Van DijkIs this the site where leptin acts upon the brain to reduce
et al., 1996; Woods and Stock, 1996; Elmquist et al.,feeding, increase energy expenditure, and regulate ac-
1997, 1998c). Although not all neurons in the brain thattivities such as sexual reproduction and generalized ac-
are affected by leptin will necessarily show expressiontivity level? Systemic injection of radiolabeled leptin re-
of Fos protein, this method allows the mapping of ex-sults in leptin binding in the choroid plexus, which
tended neuronal systems that do respond to leptin ad-contains high levels of the short form of the leptin recep-
ministration. Leptin induces Fos expression in key sitestor (Tartaglia, 1997). Leptin can enter the brain at the
surrounding the median eminence, including the lateralcircumventricular organs, but the highest level of leptin
arcuate nucleus and adjacent retrochiasmatic area, thebinding in the brain parenchyma is observed in the struc-
dorsomedial part of the ventromedial nucleus, the cau-tures surrounding the median eminence (Banks et al.,
1996), which may be critical in responding to circulating dal part of the dorsomedial nucleus, and the ventral
Review
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Figure 6. A Schematic Drawing Showing
Some of the Leptin-Activated Pathways that
Affect the Paraventricular Nucleus of the Hy-
pothalamus
Ventral parvocellular neurons of the paraven-
tricular nucleus (PVH) containing oxytocin
(OXY) innervate vagal preganglionic para-
sympathetic neurons involved in gastrointes-
tinal control. The caudal part of the dor-
somedial nucleus (DMH) provides the major
leptin-activated input to the PVH. Leptin-acti-
vated cells in the ventromedial nucleus (VMH)
project to the subparaventricular zone (SPV),
a region that also receives suprachiasmatic
nucleus (SCn) inputs and is involved in the
circadian regulation of feeding (circadian
pathways are illustrated by blue dashed
lines). The SPV in turn innervates the leptin-
activated part of the DMH. Other abbrevia-
tions are the same as in Figure 1.
premammillary nucleus (Van Dijk et al., 1996; Elmquist et shown to express leptin receptors (Mercer et al., 1996b).
However, they do not show Fos after leptin administra-al., 1997; see Figure 5). In addition, leptin administration
induces Fos expression in the ventral parvocellular part tion, presumably because they are inhibited rather than
excited by leptin administration.of the paraventricular nucleus (Van Dijk et al., 1996;
Elmquist et al., 1997), a cell group that specifically inner- Instead, the action of leptin on neuropeptide Y cells
in the arcuate nucleus has been suggested by the ex-vates the dorsal vagal complex (Saper et al., 1976; Swan-
son and Sawchenko, 1983) and that is involved in regu- pression of the suppressor of cytokine signaling 3
(SOCS-3) mRNA throughout the arcuate nucleus afterlating gastric motility and gastric acid secretion (Rogers
and Hermann, 1985). leptin administration (Bjorbaek et al., 1998). The SOCS
proteins are rapidly induced by activation of the type IThe significance of this pattern of Fos expression was
explored by combining Fos immunocytochemistry with cytokine family of receptors, which includes the leptin
receptor as well as the interleukin 6 receptor (Tartaglia,retrograde tracing of neuronal connections (see Figure
6). The Fos-immunoreactive neurons in the caudal dor- 1997; White et al., 1997). These receptors engage the
JAK tyrosine kinases, leading to phosphorylation ofsomedial nucleus provide the major leptin-responsive
input to the paraventricular nucleus (Elmquist et al., STAT protein transcription factors. SOCS proteins are
thought to act as intracellular regulators to inhibit STAT1998c). Fos-immunoreactive neurons in the ventrome-
dial nucleus, by contrast, provide a major input to the activation induced by activation of cytokine receptors
(Endo et al., 1997; Naka et al., 1997; Starr et al., 1997).subparaventricular area (Elmquist et al., 1998c). The
subparaventricular area receives the bulk of the output Specifically, SOCS-3 mRNA is rapidly induced following
leptin administration in cell groups that express the longfrom the circadian pacemaker, the suprachiasmatic nu-
cleus, and it has been implicated as a key site for inte- form of the leptin receptor (Bjorbaek et al., 1998). Fur-
thermore, SOCS-3 protein blocks leptin-induced phos-grating circadian rhythms in feeding (Watts et al., 1987).
phorylation of long-form leptin receptors. The lack of
Fos and the presence of SOCS-3 expression by medialNew Molecular Probes Identify the Arcuate Nucleus
as a Key Site in Regulating Feeding arcuate neurons suggests that the leptin receptor has
been activated, even though the net effect may be inhibi-Neuropeptide Y is a widely distributed CNS neuropep-
tide that has long been considered a major regulator tion of firing and thus expression of c-fos.
However, targeted gene deletion experiments haveof feeding (Clark et al., 1984; Kalra, 1997). Injection of
neuropeptide Y into the region of the paraventricular made it clear that regulation of neuropeptide Y systems
cannot account for the full effect of leptin. Deletion ofnucleus was shown to increase feeding and decrease
energy expenditure (Stanley and Leibowitz, 1985; Bil- the neuropeptide Y gene does not decrease food intake
or body weight or the response to starvation (Ericksonlington et al., 1994). Neurons expressing neuropeptide
Y in the medial part of the arcuate nucleus have been et al., 1996a, 1996b). When neuropeptide Y±deficient
mice are crossed with leptin-deficient (ob/ob) mice, theimplicated as at least one source of the dense inner-
vation of the paraventricular nucleus by neuropeptide neuropeptide Y knockout only partially corrects the
obese phenotype. Not only do the resultant mice remainY±containing axons (Sawchenko, 1998). The role of
these neurons in regulating feeding was reinforced by overweight (although not as extreme as the ob/ob mice),
but they also demonstrate neuroendocrine abnormali-the finding that in fasted mice neuropeptide Y mRNA is
elevated in the arcuate nucleus. A similar elevation of ties, indicating that other signaling pathways are also
involved in obesity induced by leptin deficiency.neuropeptide Y mRNA is found in ob/ob and db/db mice.
The overexpression of neuropeptide Y mRNA is blunted The receptor responsible for eliciting the effects of
neuropeptide Y on food intake also remains unsettled.in starved and leptin-deficient mice by leptin administra-
tion (Stephens et al., 1995; Ahima et al., 1996; Schwartz The neuropeptide Y type 5 (Y5) receptor was thought
to be important in regulating food intake because it iset al., 1996). As expected, neuropeptide Y neurons were
Neuron
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Figure 7. A Schematic Drawing Illustrating
the Role of the Leptin-Activated and Leptin-
Inhibited Cells in the Arcuate Nucleus of the
Hypothalamus in the Regulation of Feeding
Two counterposed populations of neurons
are involved. Neurons in the medial part of
the arcuate nucleus (ARC) express both neu-
ropeptide Y (NPY) and agouti-related pro-
tein (AgRP) (illustrated by green lines), and
they are inhibited (show SOCS-3 but not Fos
expression) by systemic leptin. A separate
population of neurons in the lateral ARC ex-
presses both a-melanocyte stimulating hor-
mone (a-MSH) and CART (illustrated by red
lines), and these cells are activated by sys-
temic leptin (show both Fos and SOCS-3 ex-
pression). Both populations of ARC neurons
project to the paraventricular nucleus (PVH)
and the lateral hypothalamic area (LHA). The
a-MSH/CART neurons also project to the
sympathetic preganglionic cell column in the
spinal cord. Other abbreviations are the same
as in Figures 1, 4, and 6.
highly expressed in the paraventricular nucleus of the (Ay/a) mutation includes both a yellow coat and an over-
eating/obesity syndrome distinct from that seen inhypothalamus and the lateral hypothalamic area (Gerald
ob/ob and db/db mice. The cloning of the agouti geneet al., 1996). However, targeted deletion of the Y5 recep-
demonstrated that the phenotype is due to ectopic over-tor does not affect normal food intake and actually leads
expression of agouti protein throughout the body (seeto adult onset obesity (Marsh et al., 1998). The Y5 knock-
Spiegelman and Flier, 1996; Graham et al., 1997; Oll-out mice respond to exogenous leptin and display nor-
mann et al., 1997). The agouti protein acts as a naturalmal compensatory hyperphagia following starvation. On
antagonist at melanocortin receptors, causing the ab-the other hand, Y5-deficient mice show blunted food
normal coat color due to antagonism of the type 1 mela-intake responses following central injections of neuro-
nocortin receptor. The observed obesity in the Ay mousepeptide Y, suggesting that Y5 receptors can drive feed-
is due to antagonism of CNS type 3 and 4 melanocortining (Erickson et al., 1996a, 1996b; Marsh et al., 1998).
receptors (Fan et al., 1997). The role of the melanocortinA second problem with our understanding of the role
systems in regulating feeding further emerged when tar-of neuropeptide Y in feeding is that the CNS targets
geted deletion of the melanocortin 4 receptor gene wasof the neuropeptide Y neurons in the medial arcuate
found to result in obesity (Huszar et al., 1997). Indeed,nucleus, which are regulated by starvation and leptin,
mutations in the human melanocortin 4 receptor alsoare not known. Although early studies emphasized a
induce obesity (Vaisse et al., 1998; Yeo et al., 1998). Theprojection from neuropeptide Y neurons in the arcuate
melanocortin 4 receptor gene is highly expressed bynucleus to the paraventricular nucleus critical for the
neurons in the paraventricular nucleus, the dorsomedialregulation of feeding, the paraventricular nucleus actu-
hypothalamic nucleus, and the lateral hypothalamic areaally receives a relatively modest input from the arcuate
(Mountjoy et al., 1994). The principle agonist ligand ofnucleus (Baker and Herkenham, 1995; C. F. E., J. K. E.,
the CNS melanocortin 4 receptor is a-melanocyte stimu-and C. B. S., unpublished data). However, the paraven-
lating hormone, a derivative of the pro-opiomelanocortintricular nucleus is innervated heavily by neuropeptide
precursor (Fan et al., 1997). Neurons expressing a-mela-
Y±containing afferents from the medulla (Sawchenko et
nocyte stimulating hormone are found in the lateral part
al., 1985). Moreover, sites in the perifornical area of the of the arcuate nucleus (Watson et al., 1978; Watson and
lateral hypothalamus are more sensitive to neuropeptide Akil, 1979).
Y±elicited feeding than is the paraventricular nucleus Several recent observations confirm the role of the
(Stanley et al., 1993). These observations suggest that pro-opiomelanocortin neurons in regulating food intake
although the arcuate neuropeptide Y neurons seem to and responding to leptin. In a very high percentage of
play an important part in the regulation of feeding, this arcuate pro-opiomelanocortin neurons, leptin receptor
may not be due entirely to projections to the paraventric- mRNA is coexpressed (Cheung et al., 1997b). Further-
ular nucleus, as was originally thought. more, in leptin-deficient ob/ob mice or in fasted rodents
(when leptin levels rapidly fall), the pro-opiomelano-
Mutually Antagonistic Melanocortin Systems cortin mRNA is markedly reduced. This decrease in
from the Arcuate Nucleus the pro-opiomelanocortin expression is prevented by
What, then, is the role of the arcuate nucleus in regulat- exogenous leptin administration (Schwartz et al., 1997;
ing food intake and body weight, and where do leptin- Thornton et al., 1997; Mizuno et al., 1998). Furthermore,
receptive arcuate neurons project? Possible answers the decrease in food intake and activation of the sympa-
have emerged from a recent set of molecular genetic thetic nervous system caused by leptin administration
observations on the importance of the central melano- can be blunted by central coadministration of a melano-
cortin receptor antagonist (Seeley et al., 1997; Satoh etcortin systems. The phenotype of the well-known agouti
Review
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Figure 8. A Schematic Drawing Summarizing
Some of the Major Pathways and Neurotrans-
mitters that Have Been Implicated in the Reg-
ulation of Feeding
Pathways that are activated by leptin (and
therefore presumably have an anorexic influ-
ence) are illustrated in red, whereas those
that are inhibited by leptin (and are presumed
to have a phagic influence) are in green. Cir-
cadian influences are illustrated by dashed
blue pathways. Leptin is proposed to exert
its effects on the hypothalamus by entering
through the median eminence. Note that a
lesion centered on the ventromedial nucleus
(VMH) and arcuate nucleus (ARC), such as
that shown in Figure 1, would eliminate leptin
influence, resulting in hyperphagia and obe-
sity. A lesion in the lateral hypothalamus (as
in Figure 1) that destroys the MCH and ORX
cells, which promote feeding, would result
in aphagia and inanition. Other abbreviations
are the same as in Figures 1, 4, 6, and 7.
al., 1998). The fundamental role of melanocortin systems CNS, including the arcuate nucleus, the lateral hypotha-
lamic area, the retrochiasmatic area, and the paraven-in regulating body weight in humans has been demon-
tricular hypothalamic nucleus (Couceyro et al., 1997;strated by the discovery of the pro-opiomelanocortin
Koylu et al., 1997, 1998). A role for CART peptides inmutations that resulted in early onset obesity (Krude et
regulating food intake was provided by the demonstra-al., 1998).
tion that injections of CART peptide into the lateral ven-Although agouti protein normally is not expressed in
tricle were found to suppress feeding (Lambert et al.,the brain, the product of a related gene that is expressed
1997, 1998; Kristensen et al., 1998). Recent evidencenormally in the mammalian brain was recently identified.
indicates that CART mRNA expression also is regulatedThis agouti-related protein (Ollmann et al., 1997; Shutter
by leptin. Specifically, like pro-opiomelanocortin, CARTet al., 1997) is found primarily in neurons in the medial
mRNA is reduced in the arcuate nucleus in leptin-defi-part of the arcuate nucleus (see Figure 2B). In addition,
cient ob/ob mice and fasted rats. Leptin administrationagouti-related protein is an antagonist at melanocor-
elevates arcuate CART mRNA levels, further suggestingtin 3 and melanocortin 4 receptors. Furthermore, overex-
that CART systems may play a role in central regulationpression of this protein results in an obesity syndrome
of feeding and body weight (Kristensen et al., 1998). Itsimilar to the Ay mouse and the melanocortin 4 receptor
is interesting to note that both cocaine and amphet-knockout mouse (Graham et al., 1997; Ollmann et al.,
amine are anorexic, and they increase the levels of CART1997). Moreover, the relative level of arcuate agouti-
mRNA, although the role of CART in mediating that an-related protein mRNA is increased with fasting, and
orexia remains conjectural.agouti-related protein and neuropeptide Y are coex-
At present, the sites within the CNS innervated bypressed in a high percentage of arcuate neurons (Bro-
leptin-regulated CART neurons that may be responsibleberger et al., 1998; Hahn et al., 1998). These observa-
for inhibition of food intake are not known. CART pep-tions predict the surprising model that two distinct and
tide±immunoreactive terminals innervate central auto-counterpoised populations of arcuate neurons, bearing
nomic sites, such as the sympathetic preganglionic neu-leptin receptors and containing melanocortin 4 receptor
rons in the spinal cord (Koylu et al., 1997, 1998). Injectionagonist and antagonist peptides, might be involved in
of retrograde tracer into the spinal cord demonstratestransmitting the leptin signal to hypothalamic sites such
that the CART inputs to the spinal cord originate in partas the lateral hypothalamic area and paraventricular nu-
from neurons in the lateral part of the arcuate nucleuscleus of the hypothalamus (see Figure 7).
and in the adjacent retrochiasmatic area (Elias et al.,
1998b; Figure 7). Furthermore, combining these markers
Getting the CART before the Source with leptin administration demonstrates that there is Fos
The role played by the arcuate nucleus of the hypothala- expression induced specifically in a high proportion of
mus in the regulation of feeding has meanwhile been these CART neurons in the arcuate nucleus and the
further illuminated by discovery of yet another molecular retrochiasmatic area (Elias et al., 1998b). In addition,
participant in this process. Investigators interested in colocalization studies indicate that virtually all CART
the regulation of gene expression induced by drugs of neurons in the arcuate and retrochiasmatic area coex-
abuse used differential display to examine the genes press pro-opiomelanocortin (Figure 3B).
expressed in the brain after the administration of co-
caine and amphetamine. One peptide, dubbed CART Connecting the Neuronal Systems for Feeding
(cocaine and amphetamine regulated transcript) was and Satiety
identified (Douglass et al., 1995). As described earlier, Recent molecular and anatomic evidence has rejuve-
nated the once dated dual center hypothesis. However,neurons expressing CART are found throughout the
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several pieces of evidence are lacking before this theory expression, and they also may mediate leptin effects
on feeding and autonomic response. The regulation ofcan be considered complete. For example, MCH and
ORX systems in the lateral hypothalamic area are regu- these apparently antagonistic populations of arcuate
neurons by leptin and the projections of these cells tolated by starvation and leptin (or lack of leptin) (Qu et
al., 1996; Sakurai et al., 1998). Leptin receptors are pres- the lateral hypothalamic area, to the paraventricular hy-
pothalamic nucleus, and to pools of autonomic pregan-ent in the lateral hypothalamic area (Fei et al., 1997;
Elmquist et al., 1998c; Hakansson et al., 1998); how- glionic neurons in the medulla and spinal cord are likely
to be critical in the regulation of food intake and bodyever, the densest collections of leptin receptors are
found in mediobasal hypothalamic cell groups, including weight.
pro-opiomelanocortin/CART (Cheung et al., 1997b) neu-
rons in the lateral arcuate nucleus and neuropeptide The Hypothalamic Regulation of Feeding:
Y/agouti-related protein (Mercer et al., 1996b) neurons A New Synthesis
in the medial arcuate nucleus. Recent anatomic studies By 1940, Hetherington and Ranson had laid to rest most
have begun to illuminate the link between leptin-regu- doubts regarding the importance of the hypothalamus
lated neurons in the arcuate nucleus and MCH and ORX in regulating body weight. However, their electrolytic
neurons in the lateral hypothalamic area. lesions were inherently crude and started debate about
Elias and colleagues (1998a) and Broberger and co- which specific hypothalamic cell groups are critical in
workers (1998) have examined the neuropeptide Y±, the control of feeding and body weight. Despite intense
agouti-related protein±, and a-melanocyte stimulating activity, during the 45 years that followed the discovery
hormone±immunoreactive axons in the lateral hypotha- of the ventromedial nucleus syndrome, we learned rela-
lamic area in mice, rats, and humans. These groups tively little about the actual pathways in the hypothala-
report intense innervation of both MCH and ORX neu- mus that mediate feeding. Because of the similarity of
rons in the lateral hypothalamic area by axons con- the leptin deficiency syndrome to the ventromedial nu-
taining all of these peptides (see Figures 1B and 2C±2E). cleus syndrome, the discovery of leptin and its receptors
Although electron microscopic confirmation of synaptic revitalized the field. In fact, the original observations of
contacts is needed, the light micrographs demonstrate Hetherington and Ranson, implicating the ªventromedial
MCH- or ORX-immunoreactive cell bodies and dendrites nucleus, but also including the adjacent arcuate nucleus
outlined and decorated with extensive pericellular net- and parts of the dorsomedial and ventral premammillary
works of terminals. Direct evidence of neuropeptide Y nucleiº in the regulation of feeding, have proven to be
receptors and melanocortin receptors on MCH and ORX both prescient and surprisingly accurate in identifying
cells is still lacking but seems likely based on avail- the hypothalamic cell groups with the highest levels of
able anatomic and genetic evidence (Mountjoy et al., long-form leptin receptors.
1994; Huszar et al., 1997; Elias et al., 1998a). The agouti- In the 4 years since the discovery of leptin, there has
related protein and a-melanocyte stimulating hormone been remarkable progress in studying the effects of
inputs likely come from the arcuate nucleus, because it starvation, leptin deprivation, and leptin administration
is the only source of agouti-related protein in the brain, on the expression of genes for transcription factors
and a-melanocyte stimulating hormone±containing neu- (c-fos), signaling molecules (SOCS-3), and neurotrans-
rons are likewise found in a very restricted distribution mitters (neuropeptide Y, agouti-related protein, a-mela-
(most are in the lateral arcuate/retrochiasmatic area and nocyte stimulating hormone, CART, MCH, and ORX) in-
a few are found in the nucleus of the solitary tract). Of volved in feeding. The availability of these molecular
equal interest is the finding that in the arcuate nucleus tools, coupled with tract tracing, has resulted in striking
there is nearly complete colocalization of neuropeptide progress in dissecting an extensive network of hypotha-
Y and agouti-related protein mRNA (Broberger et al., lamic circuitry that regulates feeding (Figure 8). Despite
1998; Hahn et al., 1998). Thus, some of the neuropeptide the fact that a number of pieces of this puzzle are still
Y innervation in the lateral hypothalamic area likely missing, the outline of the hypothalamic system for regu-
comes from the arcuate nucleus. Given that this perifor- lation of feeding is now more clear. In retrospect, the
nical region coincides with the site where injection of ventromedial nucleus itself is only a part of this network.
neuropeptide Y has its greatest effects on feeding, the It sits, however, at the epicenter of a web of pathways,
substrate for that effect may be the neuropeptide Y input running between the arcuate nucleus and the paraven-
to the perifornical MCH and ORX neurons (Stanley et tricular nucleus and lateral hypothalamus, and this epi-
al., 1993). center defines the mechanisms of neuronal regulation
Consistent with the idea that neurons in the arcuate of feeding.
nucleus convey leptin signals to the lateral hypothalamic
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